Dermata Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details

6 Months Ended

Jun. 30, 2021

4. Balance Sheet Details

The following provides certain balance sheet details:

	June 30,			December 31,
	2021			2020

Prepaid expenses and other current assets
Prepaid insurance	$	22,334		$	68,003
Prepaid clinical trial expense		-			7,050
Consulting retainer		9,532			-
Deferred offering costs		677,796			-
Total prepaid expenses and other current assets	$	709,662		$	75,053

Fixed assets
Furniture and office equipment	$	59,382		$	59,382
Computer equipment		17,225			17,225
		76,607			76,607
Less: accumulated depreciation and amortization		(76,607	)		(76,607	)
Total fixed assets, net	$	-		$	-

Accrued and other current liabilities
Accrued interest payable	$	4,937		$	49,169
Accrued vacation		91,577			84,308
Accrued printing and legal costs		490,002			-
Total accrued and other current liabilities	$	586,516		$	133,477